Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Cystic fibrosis affects many parts of the body, but its effects on the lungs can be especially harmful. Cystic fibrosis is a chronic and progressive condition that causes the mucus in your lungs to be ...

Could next-generation gene editing mean a cure for cystic fibrosis (CF)? There's been a lot of advancement on the disease in the last decade, but there are still those living with the disease who get ...

The phase 2a MYLOX-1 trial demonstrated fibrosis reduction in some patients with myelofibrosis who previously received treatment with Jakafi (ruxolitinib). A phase 2a trial of novel monotherapy GB2064 ...

Cystic fibrosis is one of many conditions that can be screened for during prenatal genetic testing. For individuals with cystic fibrosis, or for those who may be wondering if they are a carrier, there ...

Susie Rider has raised $700K for cystic fibrosis research since her daughter was diagnosed with the disease 25 years ago.

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

With this year's football game kicking off at 7 Friday night, we're taking a look at the organization and its mission for ...